Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors

Viruses. 2022 Oct 12;14(10):2242. doi: 10.3390/v14102242.

Abstract

Designed ankyrin repeat proteins (DARPins) are engineered proteins comprising consensus designed ankyrin repeats as scaffold. Tightly packed repeats form a continuous hydrophobic core and a large groove-like solvent-accessible surface that creates a binding surface. DARPin domains recognizing a target of interest with high specificity and affinity can be generated using a synthetic combinatorial library and in vitro selection methods. They can be linked together in a single molecule to build multispecific and multifunctional proteins without affecting expression or function. The modular architecture of DARPins offers unprecedented possibilities of design and opens avenues for innovative antiviral strategies.

Keywords: COVID-19; DARPin; SARS-CoV-2; ankyrin repeat protein; antiviral therapy; emerging virus; multispecificity; protein design; protein scaffold.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ankyrin Repeat
  • Designed Ankyrin Repeat Proteins*
  • HIV Fusion Inhibitors*
  • Proteins
  • Solvents
  • Virus Internalization

Substances

  • Designed Ankyrin Repeat Proteins
  • Proteins
  • HIV Fusion Inhibitors
  • Solvents

Grants and funding

S.R. and J.M. are funded by the Swiss Federal Office for Civil Protection (grants 353015349).